Results 11 to 20 of about 198,375 (333)

Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination [PDF]

, 2014
Rationale: Preeclampsia is a devastating medical complication of pregnancy which leads to maternal and fetal morbidity and mortality. While the etiology of preeclampsia is unclear, human and animal studies suggest that excessive circulating levels of ...
Hagmann, Henning, Bossung, Verena, Belaidi, Abdel Ali, Fridman, Alexander, Karumanchi, S. Ananth, Thadhani, Ravi, Schermer, Bernhard, Mallmann, Peter, Schwarz, Guenter, Benzing, Thomas, Brinkkoetter, Paul T.   +10 more
core   +8 more sources

Low molecular weight heparins [PDF]

Intensive and Critical Care Nursing, 1996
A new class of anticoagulant with advantages over standard heparin were introduced in 1990. Collectively termed low molecular weight heparins, their role is increasing in the treatment and prophylaxis of thromboembolism.
openaire   +4 more sources

Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review

Archives of Medical Science, 2021
Introduction The role of low-dose aspirin combined with low-molecular-weight heparin (LMWH) in the treatment of preeclampsia (PE) remains unclear. We aimed to assess the efficacy and safety of low-dose aspirin combined with LMWH in PE treatment, to ...
Chunfeng Wu, Liling Li, Jiarong Zhang, Yang Song   +3 more
doaj   +1 more source

Heparin-induced thrombocytopenia and acute colonic pseudo-obstruction after therapeutic anticoagulation in a very elderly patient with hip fracture: a case report

BMC Musculoskeletal Disorders, 2020
Background Hip fractures have become a severe public health problem, especially in very elderly patients. Most of them are treated with low molecular weight heparin as prophylaxis or treatment of venous thromboembolism.
Yijun Liu, Hao Lu, Hailin Xu, Zhongguo Fu, Dianying Zhang, Baoguo Jiang   +5 more
doaj   +1 more source

Present and future of low molecular weight heparin prophylaxis [PDF]

, 1999
Peer ...
Kakkar, V. V.
core   +2 more sources

The potential for circular dichroism as an additional facile and sensitive method of monitoring low-molecular-weight heparins and heparinoids [PDF]

, 2009
The ultraviolet circular dichroism (CD) spectra of commercial low-molecular-weight heparins, heparinoids and other anticoagulant preparations have been recorded between 180 and 260 nm.
Fernig, David G., Guimond, Scott E., Holman, Joseph, Lauder, Robert M., Rudd, Timothy R., Skidmore, Mark A., Turnbull, Jeremy E., Yates, Edwin A.   +7 more
core   +1 more source

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin

Clinical and Applied Thrombosis/Hemostasis, 2019
Heparin and its low-molecular-weight heparin derivatives are widely used clinical anticoagulants. These drugs are critical for the practice of medicine in applications, including kidney dialysis, cardiopulmonary bypass, and in the management of venous ...
Jianle Chen BS, Yanlei Yu PhD, Jawed Fareed PhD, Debra Hoppensteadt PhD, Walter Jeske PhD, Ahmed Kouta BS, Caijuan Jin MS, Yongsheng Jin MS, Yiming Yao MS, Ke Xia PhD, Fuming Zhang PhD, Shiguo Chen PhD, Xingqian Ye PhD, Robert J. Linhardt PhD   +13 more
doaj   +1 more source

Low-Molecular-Weight Heparin–Induced Skin Necrosis Without Thrombocytopenia

Annals of Internal Medicine: Clinical Cases, 2023
Heparin-induced skin necrosis is an immune-based entity that appears secondary to exposure to unfractionated heparin or low-molecular-weight heparin, consisting of the appearance of erythematous lesions that can progress to necrosis at the point of ...
Ana Quiles-Recuenco, Selene Falcon-Vega, Nuria Selles-Galiana, Maria Andreo-Galera, Azucena Sempere-Mira   +4 more
doaj   +1 more source

Cancer patients’ experiences of living with venous thromboembolism: A systematic review and qualitative thematic synthesis [PDF]

, 2018
Background: Cancer-Associated thrombosis is common. Recommended treatment is daily injected low-molecular-weight heparin for 6months. Most studies focus on prophylaxis and treatment; few have explored patients’ experience.
Benelhaj, Naima B., Hutchinson, Ann, Ilyas, Muhammad Waqas, Johnson, Miriam J., Maraveyas, Anthony M., Seymour, Julie D.   +5 more
core   +1 more source

The anti-cancer properties of heparin and its derivatives: a review and prospect

Cell Adhesion & Migration, 2020
Heparin, including unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and heparin derivatives, are commonly used in venous thromboembolism treatment and reportedly have beneficial effects on cancer survival.
Sai-Nan Ma, Zhi-Xiang Mao, Yang Wu, Ming-Xing Liang, Dan-Dan Wang, Xiu Chen, Ping-an Chang, Wei Zhang, Jin-Hai Tang   +8 more
doaj   +1 more source